SCHEMBL1828339

SCHEMBL1828339

[CH2]n1cc(C=O)c2ccccc21

nearest known ligand 0.61

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.61
IMPDH2 P12268 1/20 0.61
KDM4E B2RXH2 2/20 0.53
SMN1; SMN2 Q16637 6/20 0.47
HTT P42858 4/20 0.47
UBE2N P61088 1/20 0.47
LMNA P02545 3/20 0.45
MAPT P10636 2/20 0.45
NPC1 O15118 1/20 0.45
HPGD P15428 1/20 0.45
RAB9A P51151 1/20 0.45
PIM1 P11309 3/20 0.44
PIM3 Q86V86 3/20 0.44
PIM2 Q9P1W9 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
KMT2A Q03164 1/20 0.43
POLB P06746 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30078684 0.77 ALDH1A1 (0.58) ALDH1A1IMPDH2KDM4ESMN1; SMN2HTT
SCHEMBL24831720 0.77 ALDH1A1 (0.58) ALDH1A1IMPDH2KDM4ESMN1; SMN2HTT
SCHEMBL27804409 0.76 ALDH1A1 (0.61) ALDH1A1IMPDH2KDM4ESMN1; SMN2HTT
SCHEMBL16067290 0.76 ALDH1A1 (0.61) ALDH1A1IMPDH2KDM4ESMN1; SMN2HTT
SCHEMBL3831676 0.76 ALDH1A1 (0.61) ALDH1A1IMPDH2KDM4ESMN1; SMN2HTT
SCHEMBL5503150 0.76 ALDH1A1 (0.61) ALDH1A1IMPDH2KDM4ESMN1; SMN2HTT
SCHEMBL378958 0.76 ALDH1A1 (1.00) ALDH1A1IMPDH2KDM4ESMN1; SMN2HTT
SCHEMBL7202295 0.76 ALDH1A1 (0.61) ALDH1A1IMPDH2KDM4ESMN1; SMN2HTT
SCHEMBL29365374 0.76 ALDH1A1 (1.00) ALDH1A1IMPDH2KDM4ESMN1; SMN2HTT
SCHEMBL5545120 0.76 ALDH1A1 (0.61) ALDH1A1IMPDH2KDM4ESMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110230419-A1 IAP BINDING COMPOUNDS NUEVOLUTION A/S (DK) 2011-09-22 US disclosed
EP-2318363-A1 HETEROCYCLIC DERIVATIVES AS IAP BINDING COMPOUNDS Nuevolution A/S (DK) 2011-05-11 EP disclosed
WO-2009152824-A1 HETEROCYCLIC DERIVATIVES AS IAP BINDING COMPOUNDS NUEVOLUTION A/S (DK) 2009-12-23 WO disclosed
EP-1710234-A1 MALONONITRILE COMPOUND AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2006-10-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110230419-A1 IAP BINDING COMPOUNDS BIRC5, BIRC7, BIRC3 ALDH1A1 2947/4885IMPDH2 1157/4885KDM4E 2792/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.